Lat­est news on Covid vac­cine OK; No­var­tis' 1 win and 1 flop; Eli Lil­ly and the Alzheimer's puz­zle; End of an era for Al­ny­lam; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

End­points News is fir­ing on all cylin­ders. In this edi­tion you will find some big news sto­ries from the week, an in-depth fea­ture, plen­ty of ex­clu­sive re­port­ing and the first sto­ries Beth Bu­lik has writ­ten for our brand new Phar­ma Mar­ket­ing chan­nel. Sign up to re­ceive the first edi­tion of her End­points Mar­ket­ingRx newslet­ter next Tues­day — you won’t want to miss it.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.